Because histone deacetylase 1 (HDAC1) inhibition lowers pathological cardiac hypertrophy [56] and oxidative stress [57], we assessed the exosomal level of maspin, an HDAC1 inhibitor delivered by exosomes [58, 59]. The gene discussed is HDAC1; the disease is cardiac hypertrophy.